Parameter | n | (%) | |
---|---|---|---|
Age, years (median 67.0) | <65 | 37 | 35.2 |
≥65 | 68 | 64.8 | |
PSA, ng/ml [median 14.3 (2.4 − 160.7)] | <10 | 35 | 33.3 |
10 ~ 20< | 36 | 34.3 | |
20 ~ 50< | 23 | 21.9 | |
≥50 | 11 | 10.5 | |
Clinical stage | T1 | 20 | 19.0 |
T2 | 25 | 23.8 | |
T3 | 59 | 56.2 | |
T4 | 1 | 1.0 | |
Gleason score at biopsy | 5 ~ 6 | 34 | 32.4 |
7 | 33 | 31.4 | |
≥8 | 38 | 36.2 | |
Seminal vesicle invasion | − | 63 | 60.0 |
+ | 42 | 40.0 | |
Surgical margin | − | 12 | 11.4 |
+ | 93 | 88.6 | |
Microlymphatic invasion | − | 72 | 68.6 |
+ | 33 | 31.4 | |
Microvascular invasion | − | 54 | 51.4 |
+ | 51 | 48.6 | |
Perineural invasion | − | 11 | 10.5 |
+ | 94 | 89.5 | |
Gleason score at prostatectomy | 5 ~ 6 | 16 | 15.2 |
7 | 54 | 51.4 | |
≥8 | 35 | 33.3 |